SCHEMBL288792

SCHEMBL288792

NCC[C@@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34705 1.00 — —
SCHEMBL34706 1.00 — —
SCHEMBL29479228 1.00 — —
Hydrochloric Acid SCHEMBL2462827 0.97 — —
Hydrochloric Acid SCHEMBL318747 0.97 GSR (0.65) —
Hydrochloric Acid SCHEMBL318746 0.97 GSR (0.65) —
Bromide SCHEMBL29401581 0.97 — —
Bromide SCHEMBL7013646 0.97 — —
Hydrochloric Acid SCHEMBL29401163 0.97 GSR (0.65) —
Hydrochloric Acid SCHEMBL2398999 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122074077-A Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy 省卫生服务机构 2026-05-22 — — CN claimed
CN-122070294-A Stable vitreous material based on histidine, arginine and glutamic acid amino acids 阵序补丁有限公司 2026-05-19 — — CN claimed
US-12616761-B2 CXCR4-targeting compounds THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2026-05-05 — — US claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-4696700-A1 LONG-ACTING K-OPIOID RECEPTOR AGONIST Chengdu Aoda Biotechnology Co., Ltd (CN) 2026-02-18 — — EP claimed
EP-4696699-A1 ? OPIOID RECEPTOR AGONIST AND USE THEREOF Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-18 — — EP claimed
US-20260042800-A1 ANTIMICROBIAL PEPTIDOMIMETICS BASILEA PHARMACEUTICA INT AG ALLSCHWIL (CH) 2026-02-12 — — US claimed
EP-4691482-A1 LONG-ACTING CALCITONIN ANALOG Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-11 — — EP claimed
US-20260015389-A1 V1A Receptor Partial Agonist and Method of Use PHARMALN CORP (US) 2026-01-15 — — US claimed
WO-2007103584-A2 POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS NANOVIR, LLC (US) 2007-09-13 — — WO claimed
US-7049061-B1 Stereochemical control of the DNA binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-05-23 — — US claimed
US-6958240-B1 Inhibition of major groove DNA binding proteins by modified polyamides CALIFORNIA INSTIUTE OF TECHNOLOGY (US) 2005-10-25 — — US claimed
EP-1023288-A1 STEREOCHEMICAL CONTROL OF THE DNA BINDING AFFINITY, SEQUENCE SPECIFICITY, AND ORIENTATION-PREFERENCE OF CHIRAL HAIRPIN POLYAMIDES IN THE MINOR GROOVE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-08-02 — — EP claimed
EP-0973798-A1 INHIBITION OF MAJOR GROOVE DNA BINDING PROTEINS BY MODIFIED POLYAMIDES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-01-26 — — EP claimed
EP-0968186-A1 IMPROVED POLYAMIDES FOR BINDING IN THE MINOR GROOVE OF DOUBLE STRANDED DNA CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-01-05 — — EP claimed
WO-1998037066-A9 IMPROVED POLYAMIDES FOR BINDING IN THE MINOR GROOVE OF DOUBLE STRANDED DNA — 1999-02-04 — — WO claimed
WO-1998045284-A1 STEREOCHEMICAL CONTROL OF THE DNA BINDING AFFINITY, SEQUENCE SPECIFICITY, AND ORIENTATION-PREFERENCE OF CHIRAL HAIRPIN POLYAMIDES IN THE MINOR GROOVE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-10-15 — — WO claimed
WO-1998037087-A1 INHIBITION OF MAJOR GROOVE DNA BINDING PROTEINS BY MODIFIED POLYAMIDES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-08-27 — — WO claimed
WO-1998037066-A1 IMPROVED POLYAMIDES FOR BINDING IN THE MINOR GROOVE OF DOUBLE STRANDED DNA CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-08-27 — — WO claimed
Send feedback